Miguel A. Calello
University of Buenos Aires
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Miguel A. Calello.
Intervirology | 1975
Mercedes Weissenbacher; Celia E. Coto; Miguel A. Calello
Cross-protection between Junin virus and five other Tacaribe complex viruses and the serological response of guinea pigs inoculated with Tacaribe virus are reported here. Previous infection with Tamiami or Pichinde viruses significantly delayed guinea pig deaths. A 58% survival rate was found among animals immunized with three doses of Amapari virus, while guinea pigs inoculated with one dose of Machupo or Tacaribe virus were fully protected against Junin virus. Neutralization tests performed in serum samples of guinea pigs immunized with five doses of Tacaribe virus showed that they developed monologous and heterologous neutralizing antibodies.
Intervirology | 1979
Mercedes Weissenbacher; Miguel A. Calello; Orestes J. Colillas; Silvia N. Rondinone; Marcelo J. Frigerio
Experimental Junin virus infection of a New World primate, Callithrix jacchus, was evaluated. The virus produced anorexia, loss of weight, thrombocytopenia, leukopenia, and hemorrhagic and neurological symptoms and terminated in death. Virus was recovered from urine, blood samples and all tissues taken at autopsy. These preliminary observations show that several aspects of the experimental disease in C. jacchus are quite similar to severe natural Argentine hemorrhagic fever of man.
Intervirology | 1983
Mercedes Weissenbacher; Miguel A. Calello; Carlos J. Quintans; Horacio E. Panisse; Natalio M. Woyskowsky; Vicente H. Zannoli
The progression of Junin virus infection was studied in congenitally athymic mice. Immunocompetent littermates were used as infected controls. As expected, the latter developed lethal encephalitis, with viremia and considerable viral replication in the brain. The mortality rate was almost 100%; the few surviving controls exhibited high serum neutralizing antibody levels and a total absence of virus in blood and brain. In contrast, nude mice did not contract the disease; all survived with persistent viremia and virus in brain, but no serum neutralizing antibodies were detected. These results confirm previous research on thymectomized mice and those treated with anti-lymphocyte serum and tend to support the important role of cellular immunity in the pathogenesis of this viral disease.
Intervirology | 1986
Mercedes Weissenbacher; Miguel A. Calello; Susana Merani; José R. Oubiña; Ruben P. Laguens; Luis Montoro; Guadalupe Carballal
To determine the role of T lymphocytes in adult mice infected with Junin virus, 60-day-old athymic (nu/nu) mice and their immunocompetent (nu/+) littermates were inoculated intracerebrally with 10(3) TCD50 of the XJ strain. None of them exhibited neurologic illness during a 6-month observation period, and mortality was 3% for nu/nu and 7% for nu/+ animals. The main features in infected nu/nu mice were: high viral titers in brain, reaching a late peak (6.5 log/ml) 32 days postinoculation and persisting at least 6 months; low, late viremia appearing simultaneously with the viral peak in the central nervous system (CNS) and persisting up to 3 months after infection; absence of signs of neurologic disease or histologic lesions in brain and almost no mortality; and lack of detectable circulating antibodies either in IgM or in other immunoglobulins (Igs). Circulating anti-Junin antibodies were demonstrated in IgM and other Igs in immunocompetent mice, although no infectious virus or histologic lesions could be detected. These results show an important role for T lymphocytes in the clearance of Junin virus in the CNS, as demonstrated by viral persistence induced in adult athymic mice.
Intervirology | 1988
Roberto Daniel Rabinovich; Miguel A. Calello; Martha C. Boxaca; Carlos J. Quintans; Mercedes Weissenbacher
Splenocytes from Junin-virus-persistently-infected euthymic mice taken at 45 days postinfection seemed unable to induce overt signs of disease, to cause death, or to modify brain viral levels when transferred to athymic Junin-virus-infected mice. Findings differed sharply when the same recipients were transferred with splenocytes taken at 6 or 30 days postinfection from immunocompetent mice infected in adult life, since mortality reached 80 or 50%, respectively, and brain viral titers were significantly lowered. Furthermore, splenocytes taken at 6 days postinfection from whole adult mice proved harmless to persistently infected euthymic mice. These findings strongly suggest the existence of an immune system alteration in the immunocompetent mouse, attributable to Junin virus persistence. This premise is based on the fact that splenocytes from persistently infected mice were unable to recognize viral antigen expressed on recipient-infected cells. The absence or impairment of a specific cytotoxic T cell population is hereby postulated.
Journal of Medical Virology | 1986
Mercedes Weissenbacher; Miguel A. Calello; Maria Susana Merani; Marcos Rodríguez; Joseph B. McCormick
American Journal of Tropical Medicine and Hygiene | 1983
Pedro Horacio González; Ruben P. Laguens; Marcelo J. Frigerio; Miguel A. Calello; Mercedes Weissenbacher
Medical Microbiology and Immunology | 1986
Mercedes Weissenbacher; M. M. Avila; Miguel A. Calello; Maria Susana Merani; Joseph B. McCormick; Marcos Rodríguez
Journal of Medical Virology | 1983
Felisa C. Molinas; Elda Giavedoni; Marcelo J. Frigerio; Miguel A. Calello; Juan Antonio Barcat; Mercedes Weissenbacher
Journal of Medical Virology | 1988
Sergio R. Samoilovich; Miguel A. Calello; Ruben P. Laguens; Mercedes Weissenbacher